Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Scientists develop and monitor two approaches to fix blood vessel abnormalities that make tumors difficult to treat. Scientists develop and monitor two approaches to fix blood vessel abnormalities that make tumors difficult to treat. Key Takeaways
Skin drug treatments may regress dangerous birthmarks and prevent melanoma. Skin drug treatments may regress dangerous birthmarks and prevent melanoma. Key Takeaways • Researchers have developed preclinical models of a condition characterized by
Dr. Paula Rauch discusses parenting challenges from diagnosis through treatment and offers guidance to support the emotional health and well-being of children when a parent has cancer.
The team from the Collaborative Care and Community Engagement Program at Mass General Cancer Center share how they strive to improve cancer treatment for patients with mental illness.
Starting screening before age 50 is found to significantly reduce the risk and incidence of colorectal cancer in women. Starting screening before age 50 is found to significantly reduce the risk and incidence of colorectal cancer in women. Key
CAR T drives acute myeloid leukemia into submission in pre-clinical studies. CAR T drives acute myeloid leukemia into submission in pre-clinical studies. Key Takeaways • Acute myeloid leukemia is the most common leukemia in adults. • CAR T cell
If you’re looking for the taste of Spring, a salad packed with plant protein, and easy meal prep for the week, this salad “will be there for you!”
Rilzabrutinib for blood disorder shows promise in phase 1–2 clinical trial. Rilzabrutinib for blood disorder shows promise in phase 1–2 clinical trial. Key Takeaways • In an international phase 1–2 clinical trial of patients with immune
Phase 3 clinical trial results lead to approval of oral drug for red blood cell disorder. Phase 3 clinical trial results lead to approval of oral drug for red blood cell disorder. Key Takeaways • Results from a phase 3 clinical indicate that the
Diversity in U.S. medicine is not keeping pace with population changes, analysis finds. Diversity in U.S. medicine is not keeping pace with population changes, analysis finds. Key Takeaways • A new study assessed trends in the makeup of clinical
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.